Please use this identifier to cite or link to this item: https://doi.org/10.1016/S1056-8719(99)00005-2
DC FieldValue
dc.titleAccuracy of repeated blood sampling in rats: A new technique applied in pharmacokinetic/pharmacodynamic studies of the interaction between warfarin and co-enzyme Q10
dc.contributor.authorZhou, Q.
dc.contributor.authorChan, E.
dc.date.accessioned2014-10-29T01:48:02Z
dc.date.available2014-10-29T01:48:02Z
dc.date.issued1998
dc.identifier.citationZhou, Q., Chan, E. (1998). Accuracy of repeated blood sampling in rats: A new technique applied in pharmacokinetic/pharmacodynamic studies of the interaction between warfarin and co-enzyme Q10. Journal of Pharmacological and Toxicological Methods 40 (4) : 191-199. ScholarBank@NUS Repository. https://doi.org/10.1016/S1056-8719(99)00005-2
dc.identifier.issn10568719
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/105610
dc.description.abstractIn the past, combined pharmacokinetic/pharmacodynamic (PK/PD) modeling studies of oral anticoagulants in rats have been hampered by the technical problems of blood sampling. In the present study, a semi-micromethod of preparing serial plasma samples for accurate assessment of the prothrombin times (PT) and clotting factor VII activity (CFA) in rats is proposed. The method consists of orbital bleeding, blood sample weighing, gravity calculation and buffer volume adjustment. No significant differences of CFA (percentage normal) were found between citrate-diluted and undiluted plasma. This technique was employed to examine the possibility of PK/PD interaction between warfarin and Co-enzyme Q10 (CoQ10). Rats were given a single oral dose (1.5 mg/kg) of warfarin either alone or on day 4 of an 8-day oral dosing regimen of 10 mg/kg CoQ10 daily. Serial plasma and serum samples, which were subjected to respectively measurements of the anticoagulant effects and concentrations of warfarin and its main metabolites, were obtained over a 96-h period following warfarin administration. All rats survived the whole experiment and maintained a stable condition except for a marked hematocrit decrease. CoQ10 significantly augmented warfarin metabolism but showed little effect on the absorption of warfarin. CoQ10 alone had no apparent effect on either the PT or CFA. The concomitant administration of CoQ10 and warfarin does not significantly affect the anticoagulant effect of warfarin. In conclusion, the proposed serial orbital bleeding technique in rats to prepare an accurate citrate-diluted plasma for PT and CFA measurement is rapid and reliable. Copyright (C) 1999 Elsevier Science Inc.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1016/S1056-8719(99)00005-2
dc.sourceScopus
dc.subjectAnticoagulants
dc.subjectBlood coagulation
dc.subjectBlood specimen collection
dc.subjectCo-enzyme Q10
dc.subjectDrug interactions
dc.subjectPharmacokinetic/pharmacodynamic modeling
dc.subjectWarfarin
dc.typeArticle
dc.contributor.departmentPHARMACY
dc.description.doi10.1016/S1056-8719(99)00005-2
dc.description.sourcetitleJournal of Pharmacological and Toxicological Methods
dc.description.volume40
dc.description.issue4
dc.description.page191-199
dc.description.codenJPTME
dc.identifier.isiut000081988400002
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

6
checked on Aug 19, 2019

WEB OF SCIENCETM
Citations

4
checked on Aug 19, 2019

Page view(s)

41
checked on Aug 17, 2019

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.